Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.
about
Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.
@en
Prolonged interleukin-2
@nl
type
label
Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.
@en
Prolonged interleukin-2
@nl
prefLabel
Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.
@en
Prolonged interleukin-2
@nl
P2093
P2860
P1433
P1476
Prolonged interleukin-2 (IL-2) ...... ivity in renal cell carcinoma.
@en
P2093
Albertini MR
Bechhofer R
Borchert A
Goldstein D
P2860
P356
10.3109/07357909109032798
P577
1991-01-01T00:00:00Z